Tullman M - Search Results

Year	Number of Results
1977	1
1978	2
1979	2
1980	3
2000	1
2002	1
2003	1
2004	2
2005	1
2006	1
2007	1
2009	2
2010	1
2013	3
2014	2
2015	3
2018	2
2023	1
2024	0

1

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.

Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P, Arnold DL, Arnould S, Scherz T, Wolf C, Wallström E, Dahlke F; EXPAND Clinical Investigators. Kappos L, et al. Lancet. 2018 Mar 31;391(10127):1263-1273. doi: 10.1016/S0140-6736(18)30475-6. Epub 2018 Mar 23. Lancet. 2018. PMID: 29576505 Clinical Trial.

2

Evaluating multiple sclerosis.

Tullman MJ, Lublin FD. Tullman MJ, et al. J Neurol Sci. 2004 Mar 15;218(1-2):1-2. doi: 10.1016/j.jns.2003.11.001. J Neurol Sci. 2004. PMID: 14759625 No abstract available.

3

Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumab.

Bar-Or A, Aburashed R, Chinea AR, Hendin BA, Lucassen E, Meng X, Stankiewicz J, Tullman MJ, Cross AH. Bar-Or A, et al. Among authors: tullman mj. Mult Scler Relat Disord. 2023 Nov;79:104967. doi: 10.1016/j.msard.2023.104967. Epub 2023 Aug 28. Mult Scler Relat Disord. 2023. PMID: 37769429 Free article.

4

Immunotherapy of multiple sclerosis--current practice and future directions.

Tullman MJ, Lublin FD, Miller AE. Tullman MJ, et al. J Rehabil Res Dev. 2002 Mar-Apr;39(2):273-85. J Rehabil Res Dev. 2002. PMID: 12051470 Free article. Review.

5

Assessment of upper extremity function in multiple sclerosis: review and opinion.

Kraft GH, Amtmann D, Bennett SE, Finlayson M, Sutliff MH, Tullman M, Sidovar M, Rabinowicz AL. Kraft GH, et al. Among authors: tullman m. Postgrad Med. 2014 Sep;126(5):102-8. doi: 10.3810/pgm.2014.09.2803. Postgrad Med. 2014. PMID: 25295653 Review.

6

A review of current and emerging therapeutic strategies in multiple sclerosis.

Tullman MJ. Tullman MJ. Am J Manag Care. 2013 Feb;19(2 Suppl):S21-7. Am J Manag Care. 2013. PMID: 23544717 Free article. Review.

7

Glatiramer acetate therapy for multiple sclerosis: a review.

Perumal J, Filippi M, Ford C, Johnson K, Lisak R, Metz L, Tselis A, Tullman M, Khan O. Perumal J, et al. Among authors: tullman m. Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):1019-29. doi: 10.1517/17425255.2.6.1019. Expert Opin Drug Metab Toxicol. 2006. PMID: 17125414 Review.

8

Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS.

Tullman M, Chartier-Kastler E, Kohan A, Keppenne V, Brucker BM, Egerdie B, Mandle M, Nicandro JP, Jenkins B, Denys P. Tullman M, et al. Neurology. 2018 Aug 14;91(7):e657-e665. doi: 10.1212/WNL.0000000000005991. Epub 2018 Jul 20. Neurology. 2018. PMID: 30030330 Free PMC article. Clinical Trial.

9

Combination therapy in multiple sclerosis.

Tullman MJ, Lublin FD. Tullman MJ, et al. Curr Neurol Neurosci Rep. 2005 May;5(3):245-8. doi: 10.1007/s11910-005-0053-9. Curr Neurol Neurosci Rep. 2005. PMID: 15865891 Review.

10

Hepatitis B.

Tullman MJ. Tullman MJ. J Am Dent Assoc. 1980 Feb;100(2):174. doi: 10.14219/jada.archive.1980.0049. J Am Dent Assoc. 1980. PMID: 6928144 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

30 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year